Age-Related Macular Degeneration (AMD)
Age-related macular degeneration (AMD) is an eye disease, which may obscure the simple, central use of vision for activities such as reading and driving. It can be of two types−dry macular degeneration, and wet macular degeneration.
To learn more about the AMD, fill up a simple form and get latest insights freshly delivered to you in your inbox. Know more of what is cooking in the domain, read about recent happenings, key pharmaceutical companies in the Age-related Macular Degeneration market, key collaborations and deals ongoing, and treatment breakthroughs in the domain
Through DelveInsight’s newsletter, we bring to you the current trends of the Age-related macular degeneration epidemiology and treatment landscape. Receive latest on ongoing R&D, and a lot more about the disease, underlying causes, treatment options, and unmet needs in the AMD market directly in the email box.
Subscribe to DelveInsight's mailing list and never miss an update on pharmaceutical and healthcare industry.
Keep in touch.
Also, give it a good read to our latest blog: Wet Age-related Macular Degeneration: Unravelling the complex disease with comprehensive R&D
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- Key Companies
- Market insights
- Pipeline drugs
- R&D in the field
- Collaborations and deals in the domain
- Top conferences
- Support from International organizations
- Unmet needs